Oscar Health CEO buys $12M in stock via private placement, signaling cautious confidence amid losses.

Oscar Health's CEO Mark Bertolini purchased $12 million worth of company stock through a private placement, increasing his stake to nearly 11%. Unlike typical open-market buys, this transaction involved new shares issued directly by the company at fair market value, providing fresh cash without diluting shareholders significantly. Despite Oscar's significant operating losses in 2025, the company shows strong revenue growth and ambitious 2026 targets, with Bertolini's purchase reflecting management's cautious optimism. Investors should watch upcoming Q1 results before making major decisions, as the buy signals confidence but not an outright endorsement to buy aggressively.